These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. Dupuis JY; Bart B; Bryson G; Robblee J CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338 [TBL] [Abstract][Full Text] [Related]
4. Autologous transfusion and other approaches to reduce allogeneic blood exposure. Vamvakas EC; Pineda AA Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275 [TBL] [Abstract][Full Text] [Related]
5. Autologous versus allogeneic transfusion: patients' perceptions and experiences. Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337 [TBL] [Abstract][Full Text] [Related]
6. Preoperative autologous blood donation: a therapy that needs to be scientifically evaluated. Schved JF Transfus Clin Biol; 2005 Nov; 12(5):365-9. PubMed ID: 16325448 [TBL] [Abstract][Full Text] [Related]
7. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel. Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574 [TBL] [Abstract][Full Text] [Related]
8. Risks, benefits, alternatives and indications of allogenic blood transfusions. Madjdpour C; Heindl V; Spahn DR Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937 [TBL] [Abstract][Full Text] [Related]
9. Directed blood donation in pediatric general surgery: Is it worth it? Wales PW; Lau W; Kim PC J Pediatr Surg; 2001 May; 36(5):722-5. PubMed ID: 11329574 [TBL] [Abstract][Full Text] [Related]
10. The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation. Goodnough LT; Marcus RE Contemp Orthop; 1994 Dec; 29(6):430-4. PubMed ID: 10150254 [TBL] [Abstract][Full Text] [Related]
11. Transfusion and coagulation: an overview and recent advances in practice modalities. Part II: Pharmacologic adjuncts, cell salvage mechanisms, alternatives in blood donation. Viets JL; Yawn DH Nurse Anesth; 1990 Dec; 1(4):206-20. PubMed ID: 2285731 [TBL] [Abstract][Full Text] [Related]
12. Safety of RBC apheresis and whole blood donation in allogeneic and autologous blood donors. Popovsky MA Transfus Apher Sci; 2006 Apr; 34(2):205-11. PubMed ID: 16513425 [TBL] [Abstract][Full Text] [Related]
13. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness. Dietrich W; Thuermel K; Heyde S; Busley R; Berger K J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891 [TBL] [Abstract][Full Text] [Related]
14. [Measures for allogeneic blood conservation in surgery]. Mansouri Taleghani B; Grossmann R; Reith HB; Wiebecke D; Thiede A Zentralbl Chir; 2000; 125(2):111-22. PubMed ID: 10743031 [TBL] [Abstract][Full Text] [Related]
15. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Blumberg N; Kirkley SA; Heal JM Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466 [TBL] [Abstract][Full Text] [Related]
16. New transfusion strategies. Greenburg AG Am J Surg; 1997 Jan; 173(1):49-52. PubMed ID: 9046884 [TBL] [Abstract][Full Text] [Related]
17. Validation of a transfusion prediction model in head and neck cancer surgery. Krupp NL; Weinstein G; Chalian A; Berlin JA; Wolf P; Weber RS Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1297-302. PubMed ID: 14676155 [TBL] [Abstract][Full Text] [Related]
18. Strategies for minimizing the use of allogeneic blood during orthopedic surgery. Rosenblatt MA Mt Sinai J Med; 2002; 69(1-2):83-7. PubMed ID: 11832977 [TBL] [Abstract][Full Text] [Related]